Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

• Product Name Alternative:

  P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1

• Synonyms:

  Cyclin Dependent Kinase Inhibitor 2A

• UniProt:

  P51480

• Expression System:

  Prokaryotic expression

• Host:

  E. coli

• Tag:

  N-terminal His Tag

• Source:

  Prokaryotic expression

• Applications:

  Positive Control; Immunogen; SDS-PAGE; WB.

• Field of Research:

  Tumor immunity, Developmental science

• Endotoxin:

  < 1.0 EU per 1 µg (determined by the LAL method)

• Purity:

  > 97%

• Form:

  Freeze-Dried Powder

• Buffer:

  100 mM NaHCO₃, 500 mM NaCl, pH8.3, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

• Calculated Molecular Weight:

  19.8 KDa

• Observed Molecular Weight:

  20kDa

• Fragment:

  Ser3~Thr154

• Isoelectric Point:

  6.9

• Subcellular Location:

  Nucleus, Cytoplasm

• Organism Species:

  Mus musculus (Mouse)

• CAS Number:

  9000-83-3